Financial Counselors Inc Haemonetics Corp Transaction History

Financial Counselors Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$51.81 - $118.56 $115,691 - $264,744	-2,233 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$111.01 - $139.48 $86,587 - $108,794	-780 Reduced 25.89%	2,233 $248,000
Q4 2020 Feb 10, 2021	BUY	$88.75 - $119.95 $15,087 - $20,391	170 Added 5.98%	3,013 $358,000
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $215,072 - $266,047	2,843 New	2,843 $248,000
Q2 2020 Aug 07, 2020	SELL	$84.96 - $118.91 $186,487 - $261,007	-2,195 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$74.34 - $121.82 $18,585 - $30,455	250 Added 12.85%	2,195 $219,000
Q4 2019 Jan 31, 2020	BUY	$114.37 - $129.46 $27,448 - $31,070	240 Added 14.08%	1,945 $223,000
Q3 2019 Nov 08, 2019	SELL	$117.16 - $138.52 $16,402 - $19,392	-140 Reduced 7.59%	1,705 $215,000
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $39,235 - $57,763	-480 Reduced 20.65%	1,845 $222,000
Q1 2019 May 10, 2019	BUY	$83.25 - $102.12 $193,556 - $237,429	2,325 New	2,325 $203,000

337

55.2M

383K

45.1K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.12B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Counselors Inc with notifications on news.